Advances in Etiology and Prognosis of Myocardial Infarction with Non-obstructive Coronary Arteries

doi:10.12114/j.issn.1007-9572.2021.00.055

Abstract

Abstract: Myocardial infarction with non-obstructive coronary arteries（MINOCA）is a syndrome with multiple causes，which accounts for 5%-25% of acute myocardial infarction and arouses widespread concern in clinical practice in recent years.As the global definition of myocardial infarction has changed，the etiology of MINOCA may have also changed.Meanwhile，the prognosis of MINOCA remains unclear due to the influence of different causes.In this review，according to the Fourth Universal Definition of Myocardial Infarction and recent accumulating evidence on MINOCA，the etiology and diagnostic algorithm of MINOCA were further summarized，and the short-term middle-term and long-term prognosis of MINOCA were analyzed.We suggested that patients diagnosed with MINOCA should be evaluated to uncover the potential cause as far as possible for improving the prognosis，and hoped that further research would be carried out to explore the impact of different causes on the prognosis of MINOCA.

Key words: Myocardial infarction, Myocardial infarction with non-obstructive coronary arteries, Etiology, Prognosis

摘要： 冠状动脉非阻塞性心肌梗死（MINOCA）是一种多病因的临床综合征，其发病率约占急性心肌梗死的5%~25%，近年来在临床上引起普遍关注。由于最新的心肌梗死定义发生了一定变化，使得MINOCA的病因分类也随之有所不同，并且受不同病因的影响，MINOCA患者的预后情况目前尚无定论。本文结合第四版心肌梗死全球统一定义及近年来国内外MINOCA的相关研究，进一步总结归纳了MINOCA的病因及诊断流程，并对其短期预后、中长期预后分别进行了分析阐述，建议诊断为MINOCA的患者应积极探索其潜在病因，以期针对性治疗改善患者预后，并希望未来开展进一步研究探索MINOCA不同的病因对预后的影响。

关键词: 心肌梗死, 冠状动脉非阻塞性心肌梗死, 病因, 预后

ZHANG Yiman,HUANG Baotao,SHI Ruijuan, et al. Advances in Etiology and Prognosis of Myocardial Infarction with Non-obstructive Coronary Arteries　[J]. Chinese General Practice, 2021, 24(2): 132-137. DOI: 10.12114/j.issn.1007-9572.2021.00.055.
张依曼,黄宝涛,时瑞娟等. 冠状动脉非阻塞性心肌梗死的病因及预后研究进展[J]. 中国全科医学, 2021, 24(2): 132-137. DOI: 10.12114/j.issn.1007-9572.2021.00.055.

References

［1］MILLER R D，BURCHELL H B，EDWARDS J E.Myocardial infarction with and without acute coronary occlusion；a pathologic study［J］．AMA Arch Intern Med，1951，88（5）：597-604．
［2］BELTRAME J F.Assessing patients with myocardial infarction and nonobstructed coronary arteries（MINOCA）［J］．J Intern Med，2013，273（2）：182-185．
［3］AGEWALL S，BELTRAME J F，REYNOLDS H R，et al．ESC working group position paper on myocardial infarction with non-obstructive coronary arteries［J］．Eur Heart J，2017，38（3）：143-153．DOI：10.1093/eurheartj/ehw149.
［4］THYGESEN K，ALPERT J S，JAFFE A S，et al．Fourth universal definition of myocardial infarction（2018）［J］．J Am Coll Cardiol，2018，72（18）：2231-2264．DOI：10.1016/j.jacc.2018.08.1038.
［5］TAMIS-HOLLAND J E，JNEID H，REYNOLDS H R，et al．Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease：a scientific statement from the American Heart Association［J］．Circulation，2019，139（18）：e891-908．
［6］SCALONE G，NICCOLI G，CREA F.Editor's choice- pathophysiology，diagnosis and management of MINOCA：an update［J］．Eur Heart J Acute Cardiovasc Care，2019，8（1）：54-62．DOI：10.1177/2048872618782414.
［7］REYNOLDS H R，SRICHAI M B，IQBAL S N，et al．Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease［J］．Circulation，2011，124（13）：1414-1425．DOI：10.1161/circulationaha.111.026542.
［8］FALK E，NAKANO M，BENTZON J F，et al．Update on acute coronary syndromes：the pathologists' view［J］．Eur Heart J，2013，34（10）：719-728．DOI：10.1093/eurheartj/ehs411.
［9］IANNACCONE M，QUADRI G，TAHA S，et al．Prevalence and predictors of culprit plaque rupture at OCT in patients with coronary artery disease：a meta-analysis［J］．Eur Heart J Cardiovasc Imaging，2016，17（10）：1128-1137．
［10］WHITE S J，NEWBY A C，JOHNSON T W.Endothelial erosion of plaques as a substrate for coronary thrombosis［J］．Thromb Haemost，2016，115（3）：509-519．DOI：10.1160/th15-09-0765.
［11］YAMAMOTO E，YONETSU T，KAKUTA T，et al．Clinical and laboratory predictors for plaque erosion in patients with acute coronary syndromes［J］．J Am Heart Assoc，2019，8（21）：e012322．DOI：0.1161/jaha.119.012322.
［12］LEE T，MINTZ G S，MATSUMURA M，et al．Prevalence，predictors，and clinical presentation of a calcified nodule as assessed by optical coherence tomography［J］．JACC Cardiovasc Imaging，2017，10（8）：883-891．DOI：10.1016/j.jcmg.2017.05.013.
［13］OULDZEIN H，ELBAZ M，RONCALLI J，et al．Plaque rupture and morphological characteristics of the culprit lesion in acute coronary syndromes without significant angiographic lesion：analysis by intravascular ultrasound［J］．Ann Cardiol Angeiol，2012，61（1）：20-26．DOI：10.1016/j.ancard.2011.07.011.
［14］OPOLSKI M P，SPIEWAK M，MARCZAK M，et al．Mechanisms of myocardial infarction in patients with nonobstructive coronary artery disease：results from the optical coherence tomography study［J］．JACC Cardiovasc Imaging，2019，12（11 Pt 1）：2210-2221．DOI ：10.1016/j.jcmg.2018.08.022.
［15］XING L，YAMAMOTO E，SUGIYAMA T，et al．EROSION Study（effective anti-thrombotic therapy without stenting：intravascular optical coherence tomography-based management in plaque erosion）：a 1-year follow-up report［J］．Circ Cardiovasc Interv，2017，10（12）： e005860．
［16］MONTONE R A，NICCOLI G，FRACASSI F，et al．Patients with acute myocardial infarction and non-obstructive coronary arteries：safety and prognostic relevance of invasive coronary provocative tests［J］．Eur Heart J，2018，39（2）：91.
［17］NAM P，CHOI B G，CHOI S Y，et al．The impact of myocardial bridge on coronary artery spasm and long-term clinical outcomes in patients without significant atherosclerotic stenosis［J］．Atherosclerosis，2018，270：8-12．DOI：10.1016/j.atherosclerosis.2018.01.026.
［18］CHEN C，WEI J，ALBADRI A，et al．Coronary microvascular dysfunction- epidemiology，pathogenesis，prognosis，diagnosis，risk factors and therapy［J］．Circ J，2016，81（1）：3-11．
［19］MONTONE R A，NICCOLI G，RUSSO M，et al．Clinical，angiographic and echocardiographic correlates of epicardial and microvascular spasm in patients with myocardial ischaemia and non-obstructive coronary arteries［J］．Clin Res Cardiol，2020，109（4）：435-443．DOI：10.1007/s00392-019-01523-w.
［20］PIROZZOLO G，SEITZ A，ATHANASIADIS A，et al．Microvascular spasm in non-ST-segment elevation myocardial infarction without culprit lesion（MINOCA）［J］．Clin Res Cardiol，2020，109（2）：246-254．
［21］ONG P，CAMICI P G，BELTRAME J F，et al．International standardization of diagnostic criteria for microvascular angina［J］．Int J Cardiol，2018，250：16-20．DOI：10.1016/j.ijcard.2017.08.068.
［22］PASUPATHY S，AIR T，DREYER R P，et al．Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries［J］．Circulation，2015，131（10）：861-870．DOI：10.1161/circulationaha.114.011201.
［23］BILI A，MOSS A J，FRANCIS C W，et al．Anticardiolipin antibodies and recurrent coronary events：a prospective study of 1150 patients.Thrombogenic factors，and recurrent coronary events investigators［J］．Circulation，2000，102（11）：1258-1263．DOI：10.1161/01.cir.102.11.1258.
［24］STEPIEN K，NOWAK K，WYPASEK E，et al．High prevalence of inherited thrombophilia and antiphospholipid syndrome in myocardial infarction with non-obstructive coronary arteries：comparison with cryptogenic stroke［J］．Int J Cardiol，2019，290：1-6．DOI：10.1016/j.ijcard.2019.05.037.
［25］MEHTA P K，BELTRAME J F.Myocardial infarction with non-obstructive coronary arteries：a humbling diagnosis in 2018［J］．Heart，2019，105（7）：506-507．
［26］YANG C，ALFADHEL M，SAW J.Spontaneous coronary artery dissection：latest developments and new frontiers［J］．Curr Atheroscler Rep，2020，22（9）：49．
［27］SAW J，RICCI D，STAROVOTOV A，et al．Spontaneous coronary artery dissection：prevalence of predisposing conditions including fibromuscular dysplasia in a tertiary center cohort［J］．JACC Cardiovasc Interv，2013，6（1）：44-52．DOI：10.1016/j.jcin.2012.08.017.
［28］SAW J，STAROVOYTOV A，HUMPHRIES K，et al．Canadian spontaneous coronary artery dissection cohort study：in-hospital and 30-day outcomes［J］．Eur Heart J，2019，40（15）：1188-1197．DOI：10.1093/eurheartj/ehz007.
［29］KRITTANAWONG C，KUMAR A，JOHNSON KW，et al．Conditions and factors associated with spontaneous coronary artery dissection（from a national population-based cohort study）［J］．Am J Cardiol，2019，123（2）：249-253．DOI：10.1016/j.amjcard.2018.10.012.
［30］NISHIGUCHI T，TANAKA A，TARUYA A，et al．Prognosis of spontaneous coronary artery dissection treated by percutaneous coronary intervention with optical coherence tomography［J］．J Cardiol，2017，70（6）：524-529．DOI：10.1016/j.jjcc.2017.03.009.
［31］MAHMOUD A N，TADURU S S，MENTIAS A，et al．Trends of incidence，clinical presentation，and in-hospital mortality among women with acute myocardial infarction with or without spontaneous coronary artery dissection：a population-based analysis［J］．JACC Cardiovasc Interv，2018，11（1）：80-90．
［32］SAW J，HUMPHRIES K，AYMONG E，et al．Spontaneous coronary artery dissection：clinical outcomes and risk of recurrence［J］．J Am Coll Cardiol，2017，70（9）：1148-1158．DOI：10.1016/j.jacc.2017.06.053.
［33］TARANTINI G，MIGLIORE F，CADEMARTIRI F，et al．Left anterior descending artery myocardial bridging：a clinical approach［J］．J Am Coll Cardiol，2016，68（25）：2887-2899．DOI：10.1016/j.jacc.2016.09.973.
［34］SCHWARZ E R，GUPTA R，HAAGER P K，et al．Myocardial bridging in absence of coronary artery disease：proposal of a new classification based on clinical-angiographic data and long-term follow-up［J］．Cardiology，2009，112（1）：13-21．DOI：10.1159/000137693.
［35］WILLIAMS M J A，BARR P R，LEE M，et al．Outcome after myocardial infarction without obstructive coronary artery disease［J］．Heart，2019，105（7）：524-530．DOI：10.1136/heartjnl-2018-313665.
［36］ANDERSSON H B，PEDERSEN F，ENGSTROM T，et al．Long-term survival and causes of death in patients with ST-elevation acute coronary syndrome without obstructive coronary artery disease［J］．Eur Heart J，2018，39（2）：102-110．
［37］BAINEY K R，WELSH R C，ALEMAYEHU W，et al．Population-level incidence and outcomes of myocardial infarction with non-obstructive coronary arteries（MINOCA）：insights from the Alberta contemporary acute coronary syndrome patients invasive treatment strategies（COAPT）study［J］．Int J Cardiol，2018，264：12-17．DOI：10.1016/j.ijcard.2018.04.004.
［38］SMILOWITZ N R，MAHAJAN A M，ROE M T，et al．Mortality of myocardial infarction by sex，age，and obstructive coronary artery disease status in the ACTION Registry-GWTG（acute coronary treatment and intervention outcomes network registry-get with the guidelines）［J］．Circ Cardiovasc Qual Outcomes，2017，10（12）：e003443．DOI：10.1161/circoutcomes.116.003443.
［39］苏斌杰，郭长峰，李海玲，等．冠状动脉非阻塞性心肌梗死患者的临床特征、治疗现状及院内预后分析［J］．国际心血管病杂志，2019，46（1）：47-51．DOI：10.3969/j.issn.1673-6583.2019.01.011.
［40］SAFDAR B，SPATZ E S，DREYER R P，et al．Presentation，clinical profile，and prognosis of young patients with myocardial infarction with nonobstructive coronary arteries（MINOCA）：results from the VIRGO study［J］．J Am Heart Assoc，2018，7（13）： e009174．DOI：10.1161/jaha.118.009174.
［41］DREYER R P，TAVELLA R，CURTIS J P，et al．Myocardial infarction with non-obstructive coronary arteries as compared with myocardial infarction and obstructive coronary disease：outcomes in a medicare population［J］．Eur Heart J，2020，41（7）：870-878．DOI：10.1093/eurheartj/ehz403.
［42］LINDAHL B，BARON T，ERLINGE D，et al．Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease［J］．Circulation，2017，135（16）：1481-1489．DOI：10.1161/circulationaha.116.026336.
［43］CHOO E H，CHANG K，LEE K Y，et al．Prognosis and predictors of mortality in patients suffering myocardial infarction with non-obstructive coronary arteries［J］．J Am Heart Assoc，2019，8（14）：e011990．DOI：10.1161/jaha.119.011990.
［44］CILIBERTI G，COIRO S，TRITTO I，et al．Predictors of poor clinical outcomes in patients with acute myocardial infarction and non-obstructed coronary arteries（MINOCA）［J］．Int J Cardiol，2018，267：41-45．DOI：10.1016/j.ijcard.2018.03.092.
［45］HJORT M，LINDAHL B，BARON T，et al．Prognosis in relation to high-sensitivity cardiac troponin T levels in patients with myocardial infarction and non-obstructive coronary arteries［J］．Am Heart J，2018，200：60-66．DOI：10.1016/j.ahj.2018.03.005.
［46］NORDENSKJOLD A M，BARON T，EGGERS K M，et al．Predictors of adverse outcome in patients with myocardial infarction with non-obstructive coronary artery（MINOCA）disease［J］．Int J Cardiol，2018，261：18-23．DOI：10.1016/j.ijcard.2018.03.056.

[1]	ZHANG Jin, DING Zhiguo, QI Shuo, LI Ying, LI Weiqiang, ZHANG Yuanyuan, ZHOU Tong. Relationship between Serum Thyroid Hormone Levels and Prognosis during Hospitalization in Heart Failure Patients [J]. Chinese General Practice, 2023, 26(33): 4125-4129.
[2]	ZHANG Siyu, ZHOU Yuqiu, DU Xiaohui, WANG Zhengjun. Advances in Duration of Untreated Psychosis and Its Early Intervention [J]. Chinese General Practice, 2023, 26(33): 4110-4117.
[3]	WANG Yu, CHEN Yan, HAN Yuanyuan, XU Qing, CHEN Shengyue, LYU Zhibo, LU Chuan, ZHENG Mingxin, ZHAO Xin. Platelet-lymphocyte Ratio Predicts In-hospital Mortality in Elderly Patients with Acute Myocardial Infarction [J]. Chinese General Practice, 2023, 26(33): 4137-4142.
[4]	MENG Jiangtao, YANG Siyu, SUN Lei, LEI Ruining, ZHAO Xiaoxia. Advances in the Prognostic Value of Diffusion Tensor Imaging with Motor Evoked Potential for Motor Function in Cerebral Infarction Patients with Hemiplegia [J]. Chinese General Practice, 2023, 26(32): 4098-4102.
[5]	YAN Ke, WEI Wanyi, LI Shuguang, YAO Weinan, DONG Jing, WANG Xiaobin, ZHANG Xueyuan, YANG Jie, SHEN Wenbin, ZHU Shuchai. Effect of Consolidation Chemotherapy on Prognosis of StageⅡ-Ⅲ Esophageal Squamous Cell Carcinoma Patients Treated with Definitive Concurrent Chemotherapy and Radio-therapy [J]. Chinese General Practice, 2023, 26(30): 3772-3779.
[6]	YAN Ke, WEI Wanyi, DENG Wenzhao, SHEN Wenbin, LI Shuguang, DU Xingyu, ZHANG Xueyuan, YANG Jie, ZHU Shuchai. Long-term Prognosis Analysis and Influencing Factors of Concurrent Chemotherapy and Radio-therapy for Cervical and Upper Thoracic Esophageal Squamous Cell Carcinoma [J]. Chinese General Practice, 2023, 26(30): 3785-3790.
[7]	SHI Xiaoqi, LUO Nandu, HUANG Jiaojiao, DU Zuochen, HUANG Pei, CAO Xiuli, CHEN Yan, HE Zhixu. Correlation between Aspartate Aminotransferase/Alanine Aminotransferase and Prognosis of Hemophagocytic Lymphohistiocytosis in Children [J]. Chinese General Practice, 2023, 26(30): 3801-3808.
[8]	WANG Zhen, SHEN Guoqi, LI Yanan, ZHU Yinghua, QIU Hang, ZHENG Di, XU Tongda, LI Wenhua. Development and Validation of a Risk Prediction Model for Contrast-induced Acute Kidney Injury after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction [J]. Chinese General Practice, 2023, 26(29): 3650-3656.
[9]	MIAO Guangrui, PANG Shuo, ZHOU Yuanhang, DUAN Mingxuan, BAI Linpeng, ZHANG Qingyang, ZHAO Xiaoyan, DONG Jianzeng. Short-term Prognostic Value of Early Fluid Balance and Lactate Clearance in Patients with Acute Myocardial Infarction Combined with Cardiogenic Shock Treated with Extracorporeal Membrane Oxygenation [J]. Chinese General Practice, 2023, 26(27): 3397-3402.
[10]	TANG Shilan, XIE Kexin, LIU Lingyu, QI Tiantian, YANG Yansui. Advances in Rehabilitation Outcomes and Care in Patients with Prolonged Disorders of Consciousness [J]. Chinese General Practice, 2023, 26(27): 3342-3348.
[11]	SUN Shuaigang, SHENG Xiaoxiao, ZHANG Wenhui, TIAN Huijuan, ZHAI Yaling. The Analysis of Clinicopathological Characters and Short-term Prognosis in Idiopathic Membranous Nephropathy Patients with Immunoglobulin G4 Combined with Other Different Immunoglobulin G Subtypes Deposition [J]. Chinese General Practice, 2023, 26(21): 2632-2638.
[12]	CHEN Yan, CHEN Shengyue, HAN Yuanyuan, LYU Zhibo, XU Qing, ZHAO Xin. Combined Predictive Value of Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio for In-hospital Mortality Risk in Patients with Acute Myocardial Infarction [J]. Chinese General Practice, 2023, 26(20): 2482-2487.
[13]	ZHAO Zewei, KANG Ning, GUO Fengli, WANG Zhongyu, ZHENG Xiangqian. Effect of Aurora Kinase A Expression on Biochemical Cure in Patients after Medullary Thyroid Cancer Resection [J]. Chinese General Practice, 2023, 26(20): 2508-2512.
[14]	ZHANG Kang, JI Wenshuai, KONG Xinxin, DU Chen, XIE Kai, WANG Haifeng. Predictive Efficacies of SOFA Score, CURB-65 Score and PSI Score for 28-day Mortality in Patients with Severe Pneumonia: a Comparative Study [J]. Chinese General Practice, 2023, 26(18): 2217-2222,2226.
[15]	WANG Jun, WU Jiafei, WANG Yijing, ZHENG Boyue, WANG Yu, JIANG Chuanyan, LI Hui. Efficacy and Prognostic Effect of Daratumumab-based Chemotherapy Regimen in Multiple Myeloma: a Real-world Study [J]. Chinese General Practice, 2023, 26(18): 2256-2262.